Bristol-Myers Squibb
BMY
BMY
1,763 hedge funds and large institutions have $62.7B invested in Bristol-Myers Squibb in 2018 Q4 according to their latest regulatory filings, with 208 funds opening new positions, 555 increasing their positions, 747 reducing their positions, and 155 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,763
Holders Change
+36
Holders Change %
+2.08%
% of All Funds
39.34%
Holding in Top 10
41
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-2.38%
% of All Funds
0.91%
New
208
Increased
555
Reduced
747
Closed
155
Calls
$1.13B
Puts
$1.14B
Net Calls
-$12.3M
Net Calls Change
-$94.7M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$500M |
| 2 |
Millennium Management
New York
|
+$254M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$211M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$196M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$173M |
